The therapy of lyme neuroborreliosis

被引:0
作者
Pachner A.R. [1 ]
机构
[1] Department of Neurology, UMDNJ-New Jersey Medical School, Newark, NJ 07103
关键词
Lyme Disease; Main Side Effect; Main Drug Interaction; Borrelia Burgdorferi; Lyme Borreliosis;
D O I
10.1007/s11940-005-0026-y
中图分类号
学科分类号
摘要
The challenge for the neurologist in the treatment of Lyme neuroborreliosis is not in the treatment per se, but in the diagnosis. Neurological manifestations of Lyme disease can present in many forms, and diagnostic techniques which detect the spirochete directly; the culture or polymerase chain reaction of the spirochete in cerebrospinal fluid, are of disappointingly low yield. Therefore, the diagnosis is frequently not easy. After the diagnosis is made, antibiotic therapy is straightforward; Lyme neuroborreliosis should be treated with at least 2 weeks of antibiotics. In the United States, intravenous therapy with ceftriaxone or penicillin for 2 weeks is the standard, whereas in Europe oral doxycycline therapy is commonly administered. Either is effective, and my choice of therapy generally depends on the patient. Many patients have symptoms which continue after antibiotic therapy referable to persistent inflammation, and, for those patients, I will commonly prescribe nonsteroidal anti-inflammatory medications. Copyright © 2005 by Current Science Inc.
引用
收藏
页码:167 / 170
页数:3
相关论文
共 19 条
[1]  
Pachner A.R., Gelderblom H., Cadavid D., The rhesus model of Lyme neuroborreliosis, Immunol. Rev., 183, pp. 186-204, (2001)
[2]  
Karlsson M., Hovind-Hougen K., Svenungsson B., Stiernstedt G., Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis, J. Clin. Microbiol., 28, pp. 473-479, (1990)
[3]  
Pachner A.R., Dail D., Bai Y., Et al., Genotype determines phenotype in experimental Lyme borreliosis, Ann. Neurol., 56, pp. 361-370, (2004)
[4]  
Clark J.R., Carlson R., Sasaki C.T., Et al., Facial paralysis in Lyme disease, Laryngoscope, 95, pp. 1341-1345, (1985)
[5]  
Pachner A.R., Steere A.C., The triad of neurologic manifestations of Lyme disease: Meningitis, cranial neuritis, and radiculoneuritis, Neurology, 35, pp. 47-53, (1985)
[6]  
Bannwarth A.L., Chronische lymphocytare Meningitis, entzundliche Polyneuritis und "Rheumatismus" Ein Beitrag zum Problem "Allergie und Nervensystem, Arch. Psychiat. Nervenkr, 113, pp. 284-376, (1941)
[7]  
Kaiser R., Neuroborreliosis, J. Neurol., 245, pp. 247-255, (1998)
[8]  
Hansen K., Lebech A.M., The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production, Brain, 115, pp. 399-423, (1992)
[9]  
Tumani H., Nolker G., Reiber H., Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis, Neurology, 45, pp. 1663-1670, (1995)
[10]  
Reiber H., Lange P., Quantification of virus-specific antibodies in cerebrospinal fluid and serum: Sensitive and specific detection of antibody synthesis in brain, Clin. Chem., 37, pp. 1153-1160, (1991)